Skip Navigation
CNBC
Markets
  • Pre-Markets
  • U.S. Markets
  • Currencies
  • Cryptocurrency
  • Futures & Commodities
  • Bonds
  • Funds & ETFs
Business
  • Economy
  • Finance
  • Health & Science
  • Media
  • Real Estate
  • Energy
  • Climate
  • Transportation
  • Investigations
  • Industrials
  • Retail
  • Wealth
  • Sports
  • Life
  • Small Business
Investing
  • Personal Finance
  • Fintech
  • Financial Advisors
  • Options Action
  • ETF Street
  • Buffett Archive
  • Earnings
  • Trader Talk
Tech
  • Cybersecurity
  • AI
  • Enterprise
  • Internet
  • Media
  • Mobile
  • Social Media
  • CNBC Disruptor 50
  • Tech Guide
Politics
  • White House
  • Policy
  • Defense
  • Congress
  • Expanding Opportunity
Video
  • Latest Video
  • Full Episodes
  • Livestream
  • Live Audio
  • Live TV Schedule
  • CNBC Podcasts
  • CEO Interviews
  • CNBC Documentaries
  • Digital Originals
Watchlist
Investing Club
  • Trust Portfolio
  • Analysis
  • Trade Alerts
  • Meeting Videos
  • Homestretch
  • Jim's Columns
  • Education
  • Subscribe
Join IC
PRO
  • Pro News
  • Josh Brown
  • Mike Santoli
  • Calls of the Day
  • My Portfolio
  • Livestream
  • Full Episodes
  • Stock Screener
  • Market Forecast
  • Options Investing
  • Chart Investing
  • Subscribe
Join Pro
Livestream
  • Make It
  • select
  • USA
  • INTL
  • Livestream
  • Livestream
Watchlist
SIGN IN
Create free account
Markets
Business
Investing
Tech
Politics
Video
Watchlist
Investing Club
Join IC
PRO
Join Pro
Livestream

Business News

Health and Science

  • Coronavirus
  • Biotech and Pharma
  • Health Insurance
  • Hospitals
  • Science
2026 will bring more GLP-1 weight loss pills — and new habits. These stocks are poised to benefit
2026 will bring more GLP-1 weight loss pills — and new habits. These stocks are poised to benefit
Christina Cheddar BerkThu, Jan 1st 2026
Lilly investors shouldn’t sweat rival Novo having the first obesity pill on sale
Lilly investors shouldn’t sweat rival Novo having the first obesity pill on sale
Morgan ChittumTue, Dec 23rd 2025
Wegovy-maker Novo Nordisk shares surge after GLP-1 weight loss pill approval
Wegovy-maker Novo Nordisk shares surge after GLP-1 weight loss pill approval
Elsa OhlenTue, Dec 23rd 2025
FDA approves first GLP-1 pill for obesity from Wegovy maker Novo Nordisk
FDA approves first GLP-1 pill for obesity from Wegovy maker Novo Nordisk
Annika Kim ConstantinoMon, Dec 22nd 2025
The donors, insiders and data behind Trump’s marijuana executive order
The donors, insiders and data behind Trump’s marijuana executive order
Luke FountainFri, Dec 19th 2025
UnitedHealth Group commits to improvements after independent audit results
Health and Science
UnitedHealth Group commits to improvements after independent audit results
Fri, Dec 19th 2025
Wall Street banked on a flurry of deals in 2025. It wasn't that simple
Mergers
Wall Street banked on a flurry of deals in 2025. It wasn't that simple
Fri, Dec 19th 2025
Marijuana
Trump signs executive order reclassifying weed, opening door to broader access
Thu, Dec 18th 2025
Health and Science
Eli Lilly says obesity pill helps maintain weight loss after Wegovy, Zepbound 
Thu, Dec 18th 2025
Health and Science
Medical supply firm Medline jumps more than 40% in debut after biggest IPO of 2025
Wed, Dec 17th 2025

Trending Now

  • 1
    Bernie Sanders and Ron DeSantis speak out against data center boom. It's a bad sign for AI industry
  • 2
    He's been walking around the world for 27 years. One of the biggest lessons he's learned is how to be happy
  • 3
    This investment account is 'like a super-powered Roth,' expert says. And 6 million more Americans are now eligible to contribute
  • 4
    Look inside: He built this treehouse in the woods for $175,000 —now it rents for up to $700 a night
  • 5
    Student loan forgiveness is taxable again: Start planning for the 'tax bomb,' CFP says

More In Health and Science

Healthy Returns: 2026 will be the year of obesity pills
Healthy Returns
Healthy Returns: 2026 will be the year of obesity pills
Tue, Dec 16th 2025
Pfizer’s modest 2026 outlook shows its big investments will take time to pay off
Health and Science
Pfizer’s modest 2026 outlook shows its big investments will take time to pay off
Tue, Dec 16th 2025
Trump says he's 'strongly' considering reclassifying pot via executive order
Markets
Trump says he's 'strongly' considering reclassifying pot via executive order
Mon, Dec 15th 2025
Markets
Why Wall Street and Jim Cramer think Danaher stock is 'ready to go for a romp'
Mon, Dec 15th 2025
CNBC Investigations
FDA approved a Singapore work trip during government shutdown, records show
Mon, Dec 15th 2025
Healthy Returns
Healthy Returns: FDA may add its strongest safety warning to Covid vaccines
Fri, Dec 12th 2025
‘The next protein’: Fiber is shaping up to be the latest grocery obsession
Food & Beverage
‘The next protein’: Fiber is shaping up to be the latest grocery obsession
Fri, Dec 12th 2025
Danish drug maker outlines ambitious 2030 strategy, ramping up pressure on Novo, Lilly
Biotech and Pharma
Danish drug maker outlines ambitious 2030 strategy, ramping up pressure on Novo, Lilly
Thu, Dec 11th 2025
Eli Lilly obesity drug delivers weight loss, reduces knee pain in trial
Health and Science
Eli Lilly obesity drug delivers weight loss, reduces knee pain in trial
Thu, Dec 11th 2025
Health and Science
Eli Lilly to build $6 billion Alabama manufacturing plant for obesity pill
Tue, Dec 9th 2025
A biotech stock for investors scared to invest in the risky industry
Tue, Dec 9th 2025
Pharmaceuticals
FDA approves Merck treatment for decimated U.S. cattle herds to stop screwworm
Tue, Dec 9th 2025
Pfizer adds to obesity bet with up to $2.1 billion deal with Chinese company
Health and Science
Pfizer adds to obesity bet with up to $2.1 billion deal with Chinese company
Tue, Dec 9th 2025
Bill Gates on why AI will become 'hyper competitive'
AI
Bill Gates on why AI will become 'hyper competitive'
Tue, Dec 9th 2025
RFK Jr.’s vaccine panel weakens recommendation on hepatitis B shot for babies
Health and Science
RFK Jr.’s vaccine panel weakens recommendation on hepatitis B shot for babies
Fri, Dec 5th 2025
Health and Science
RFK Jr.'s vaccine panel defers vote on hepatitis B shot for babies until Friday
Thu, Dec 4th 2025
Analysis
Jim Cramer has faith in Danaher's turnaround as life sciences comes back to life
Tue, Dec 2nd 2025
CNBC Changemakers
CEO using ChatGPT to talk to AI clones of business icons: 'Advice was so good'
Mon, Dec 8th 2025
Eli Lilly slashes cash prices of Zepbound weight loss drug vials
Health and Science
Eli Lilly slashes cash prices of Zepbound weight loss drug vials
Mon, Dec 1st 2025
Abortion pill access steady under Trump as FDA review looms
Biotech and Pharma
Abortion pill access steady under Trump as FDA review looms
Tue, Nov 25th 2025
Republicans push Obamacare tax credit alternatives as enrollment deadline looms
Health and Science
Republicans push Obamacare tax credit alternatives as enrollment deadline looms
Tue, Nov 25th 2025
Health and Science
Novo Nordisk shares plunge after Alzheimer's drug trial fails to hit key target
Mon, Nov 24th 2025
Health and Science
Eli Lilly hits $1 trillion market value as Novo Nordisk tumbles
Mon, Nov 24th 2025
CNBC Changemakers
Why America's broken health system is an opportunity: Cityblock CEO Toyin Ajayi
Mon, Dec 8th 2025
CNBC logo
  • Subscribe to CNBC PRO
  • Subscribe to Investing Club
  • Licensing & Reprints
  • CNBC Councils
  • Select Personal Finance
  • Join the CNBC Panel
  • Closed Captioning
  • Digital Products
  • News Releases
  • Internships
  • Corrections
  • About CNBC
  • Site Map
  • Podcasts
  • Careers
  • Help
  • Contact
  • News Tips

    Got a confidential news tip? We want to hear from you.

    Get In Touch
  • CNBC Newsletters

    Sign up for free newsletters and get more CNBC delivered to your inbox

    Sign Up Now

    Get this delivered to your inbox, and more info about our products and services.

  • Advertise With Us

    Please Contact Us
  • Ad Choices
  • Privacy Policy
  • California Consumer Privacy Act (CCPA) Opt-Out IconYour Privacy Choices
  • CA Notice
  • Terms of Service

© 2025 Versant Media, LLC. All Rights Reserved. A Versant Media Company.

Data is a real-time snapshot *Data is delayed at least 15 minutes. Global Business and Financial News, Stock Quotes, and Market Data and Analysis.

Market Data Terms of Use and Disclaimers

Data also provided byReuters logo